PMID: 9633030Jun 20, 1998Paper

Can syringe exchange serve as a conduit to substance abuse treatment?

Journal of Substance Abuse Treatment
R Heimer

Abstract

To determine how the city-run New Haven syringe exchange program (SEP) expedited requests, for entry into treatment, records of the SEP's drug treatment coordinator were analyzed. During the study period, a majority of those requesting treatment did not use the SEP to obtain sterile syringes. Comparisons between the people requesting treatment and those exchanging syringes revealed that those requesting treatment were more likely female and less like White. Factors associated with failure to enter treatment included long lag times, worse insurance, cocaine use, and requesting primary detoxification only. Majorities of the requests, appointments, and entries came from individuals whose treatment was to be paid through city welfare. A managed care initiative from the city welfare department, which excluded the SEP, halved requests or entries. Subsequent addition of the SEP to the initiative did not significantly increase requests or entries. Although the SEP initially acted as a conduit to treatment its effectiveness was curtailed by the imposition of bureaucratic restrictions.

References

May 1, 1995·The International Journal of the Addictions·J R Caplehorn, M W Ross
Feb 1, 1995·Journal of Clinical Psychopharmacology·N W WithersJ C Gillin
May 1, 1994·AIDS·E H Kaplan, R Heimer
May 1, 1996·American Journal of Public Health·S D Holmberg

❮ Previous
Next ❯

Citations

Apr 16, 2003·Journal of Policy Analysis and Management : [the Journal of the Association for Public Policy Analysis and Management]·H A Pollack
Dec 28, 1999·Journal of Urban Health : Bulletin of the New York Academy of Medicine·S A StrathdeeD Vlahov
Sep 8, 2000·Journal of Urban Health : Bulletin of the New York Academy of Medicine·H BrahmbhattS A Strathdee
Feb 8, 2006·AIDS and Behavior·Steffanie A Strathdee, Thomas L Patterson
Jun 6, 2006·The Journal of Behavioral Health Services & Research·Dennis D DeckKatherine E Laws
Apr 11, 2001·Drug and Alcohol Dependence·R N BluthenthalM Stein
Feb 5, 2002·Journal of Psychoactive Drugs·F D Wittman
May 25, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Frederick L AlticeGerald H Friedland
Nov 17, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Lynn E SullivanDavid A Fiellin
Aug 17, 2004·AIDS Patient Care and STDs·Steffanie Strathdee
Dec 7, 2002·Journal of Urban Health : Bulletin of the New York Academy of Medicine·Robert HeimerMerrill Singer
Mar 5, 2005·Journal of Urban Health : Bulletin of the New York Academy of Medicine·Frederick L AlticeMarta I Buitrago
Jul 15, 2005·Journal of Urban Health : Bulletin of the New York Academy of Medicine·Michael KidorfRobert K Brooner
May 19, 2001·Australian and New Zealand Journal of Public Health·D Rouen, K Dolan
Jun 24, 2008·Science & Practice Perspectives·James L SorensenDavid C Perlman
Apr 26, 2006·Journal of Ethnicity in Substance Abuse·Grace L ReynoldsHenry H Cagle
Apr 7, 2007·AIDS Education and Prevention : Official Publication of the International Society for AIDS Education·Carmen L MassonSharon M Hall
Jun 19, 2010·American Journal of Public Health·Thomas KerrEvan Wood
Dec 9, 2000·American Journal of Public Health·M A MarxS A Strathdee
Dec 9, 2000·American Journal of Public Health·E R Weitzman, I Kawachi
Jul 1, 2006·Substance Use & Misuse·Susan G Sherman
Jul 1, 2006·Substance Use & Misuse·Jennifer LorvickAlex H Kral
Jul 1, 2006·Substance Use & Misuse·Kevin IrwinLarissa Badrieva
Aug 3, 2010·The American Journal of Drug and Alcohol Abuse·Orion MowbrayMichael G Vaughn
May 28, 2013·Journal of Substance Abuse Treatment·Paul Truman HarrellW W Latimer
Aug 13, 2011·Journal of Substance Abuse Treatment·Michael KidorfRobert K Brooner
Oct 7, 2008·Journal of Substance Abuse Treatment·Jennifer R HavensSteffanie A Strathdee
May 16, 2007·Infectious Disease Clinics of North America·Carla J BergSteven A Safren
May 6, 2009·Addiction·Michael KidorfRobert K Brooner
May 26, 2007·Addiction·Steffanie A Strathdee, Robin A Pollini
Jan 12, 2011·Drug and Alcohol Review·Joan MacNeil, Bernadette Pauly
Jun 6, 2002·Journal of General Internal Medicine·Harold A PollackFrederick L Altice
Jan 3, 2012·Drug and Alcohol Dependence·Michael KidorfRobert K Brooner
May 15, 2012·The International Journal on Drug Policy·Elaine HyshkaThomas Kerr
Nov 26, 2013·Harm Reduction Journal·Eleanor Hayes-LarsonRobert Heimer

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.